Calidi Biotherapeutics (CLDI) Current Leases (2022 - 2026)

Calidi Biotherapeutics has reported Current Leases for 5 years, with the latest figure at $1.0 million in Q2 2026.

• On a quarterly basis, Current Leases fell 22.62% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 22.62% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, up 16.69% from the prior year.
• Current Leases was $1.0 million for Q2 2026 at Calidi Biotherapeutics, down from $1.4 million in the prior quarter.
• The five-year high for Current Leases was $1.4 million in Q4 2025, with the low at $47000.0 in Q3 2022.
• Average Current Leases over 5 years is $993733.3, with a median of $1.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Current Leases surged 2014.89% in 2023, then slipped 22.62% in 2026.
• Over 5 years, Current Leases stood at $72000.0 in 2022, then surged by 1337.5% to $1.0 million in 2023, then rose by 16.33% to $1.2 million in 2024, then increased by 16.69% to $1.4 million in 2025, then declined by 28.19% to $1.0 million in 2026.
• The last three Current Leases figures came in at $1.0 million (Q2 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.